Abstract

The PHARMINE (“Pharmacy Education in Europe”) project studied the organisation of pharmacy education, practice and legislation in the European Union (EU) with the objectives of evaluating to what degree harmonisation had taken place with the EU, and producing documents on each individual EU member state. Part of this work was in the form of a survey of pharmacy education, practice, and legislation in the various member states. We will publish the individual member state surveys as reference documents. This paper presents the results of the PHARMINE survey on pharmacy education, training, and practice in the Czech Republic. Czech community pharmacies sell and provide advice on Rx and Over-the-counter (OTC) medicines; they also provide diagnostic services (e.g., blood pressure measurement). Pharmacists (lékárník in Czech) study for five years and graduate with a Magister (Mgr., equivalent to M.Pharm.) degree. The Mgr. diploma is the only requirement for registration as a pharmacist. Pharmacists can own and manage community pharmacies, or work as responsible pharmacists in pharmacies. All practising pharmacists must be registered with the Czech Chamber of Pharmacists. The ownership of a community pharmacy is not restricted to members of the pharmacy profession; the majority of pharmacies are organised into various pharmacy chains. There are two universities providing higher education in pharmacy in the Czech Republic: the Faculty of Pharmacy in Hradec Kralove, Charles University, which was established in 1969, and the Faculty of Pharmacy of the University of Veterinary and Pharmaceutical Sciences in Brno, which was established in 1991. The pharmacy curriculum is organized as a seamless, fully integrated, five-year master degree course. There is a six-month traineeship supervised by the university, which usually takes place during the fifth year. Thus, the pharmacy curriculum is organised in accordance with the EU directive on sectoral professions that lays down the imperatives for pharmacy education, training, and practice in the various member states of the EU. Currently, no specialisation courses are available at the university level. Specialisation is organised in the form of postgraduate, continuing professional development by the Czech Chamber of Pharmacists, and delivered by the Institute of Postgraduate Education for Health Professions.

Highlights

  • The PHARMINE (“Pharmacy Education in Europe”) consortium surveyed the state of pharmacy education and practice in the member states of the European Union (EU), including the Czech Republic, in 2012, with an update in 2017

  • The pharmacy curriculum is organised in accordance with the EU directive on sectoral professions that lays down the imperatives for pharmacy education, training, and practice in the various member states of the EU

  • Education Area, proposes a bachelor plus master degree structure for all of the degrees, including pharmacy. This agreement is in opposition to the EU directive that stipulates a five-year “tunnel” degree structure for pharmacy, i.e., a degree course that has no possibility for intermediate entry or exit, for example, after a three-year bachelor period

Read more

Summary

Introduction

The PHARMINE (“Pharmacy Education in Europe”) consortium surveyed the state of pharmacy education and practice in the member states of the EU, including the Czech Republic, in 2012, with an update in 2017. Education Area (which includes the 28 EU member states), proposes a bachelor (three years) plus master (two years) degree structure for all of the degrees, including pharmacy This agreement is in opposition to the EU directive that stipulates a five-year “tunnel” degree structure for pharmacy, i.e., a degree course that has no possibility for intermediate entry or exit, for example, after a three-year bachelor period. Another aspect of the Bologna process is the development of tools to promote exchange, such as the European Credit Transfer and Accumulation System (ECTS), which provides credits to students for defined learning outcomes and their associated workload. Health expenditure is mainly in the public sector ($2013) rather than in the private sector ($69)

Design
Evaluation and Assessment
Method
Subject Areas
Discussion and Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.